跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Heparinase I
首页
药物
Heparinase I
Heparinase I
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Hemostatic compositions, devices and methods
US 7094428 B2
申请人: UNIV NEW JERSEY MED
优先权: 2002
US
2 件公开
Rationally designed heparinases derived from heparinase I and II and methods of sequencing therewith
US 7560106 B2
申请人: MASSACHUSETTS INST TECHNOLOGY
优先权: 2005
US
2 件公开
Purification of Heparinase I, II, and III from Flavobacterium heparinum
US RE41328 E
申请人: MASSACHUSETTS INST TECHNOLOGY
优先权: 2008
US
2 件公开
Heparinase I fusion protein and genes encoding same and expression method thereof
CN 1699424 A
申请人: UNIV TSINGHUA
优先权: 2004
CN
Method for preparing low molecular weight heparin
CN 101294177 B
申请人: UNIV TSINGHUA
优先权: 2008
CN
Methods for analyzing or processing a heparin sample
US 8173384 B2
申请人: SASISEKHARAN RAM
优先权: 2009
US
High-expression and high-activity bacteroides thetaiotaomicron heparinase I fusion protein, and encoding gene and application thereof
CN 109385412 A
申请人: UNIV TIANJIN SCIENCE & TECH
优先权: 2018
CN
Method for preparing recombinant heparinase I by utilizing SUMO fusion expression system and SUMO-heparinase I fusion protein prepared by method
CN 112980820 A
申请人: SHANGHAI BAOWEI PHARMACEUTICAL TECH CO LTD
优先权: 2021
CN
埃氏拟杆菌肝素酶I融合蛋白及其编码基因和制备方法
CN 115975040 B
申请人: 重庆东渝中能实业有限公司
优先权: 2022
CN
药物
反馈